Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.0001 USD
Change Today 0.00 / 0.00%
Volume 0.0
INOL On Other Exchanges
As of 8:10 PM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

inolife technologies inc (INOL) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/2/14 - $0.0018
52 Week Low
12/5/14 - $0.0001
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

inolife technologies inc (INOL) Related Businessweek News

No Related Businessweek News Found

inolife technologies inc (INOL) Details

Inolife Technologies, Inc., a development stage company, focuses on marketing healthcare products for individuals, physicians, hospitals, and outpatient facilities in the United States. Its products include DNA testing for Plavix; and pre-disposition screening for certain genetic diseases, and ancestry and paternity tests. The company is based in Raleigh, North Carolina.

6 Employees
Last Reported Date: 07/15/14

inolife technologies inc (INOL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

inolife technologies inc (INOL) Key Developments

Inolife Technologies, Inc. announced delayed annual 10-K filing

On 06/30/2015, Inolife Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Inolife Technologies, Inc. Announces Board and Management Changes

By the unanimous written consent board of directors on March 31, 2015, the Board of Directors of Inolife Technologies, Inc. accepted the resignation of Gary Berthold as officer and director of the company, which became effective immediately after the Closing and concurrently appointed Elizabeth A. Cirone as Chief Executive Officer and director of the company and Mark Corrao as Chief Financial Officer and Secretary of the company. Since 2001, Ms. Cirone has been the owner and Chairperson of Segal Cirone Services, Inc. Mark Corrao has been a Partner of The Mariner Group since 2013 and continues to serve as the Managing Director of The CFO Squad since the merger of The Mariner Group LLC and The CFO Squad.

Inolife Plans To Acquire Biopharma-Based Operating Business

Inolife Technologies, Inc. (OTCPK:INOL) received $0.05 million in funding. Inolife Technologies will be using the proceeds from the sale of the note to spin off its existing service-based healthcare product marketing business, bring in new management and acquire a biopharma-based operating business with growth potential.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INOL:US $0.00 USD 0.00

INOL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INOL.
View Industry Companies

Industry Analysis


Industry Average

Valuation INOL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOLIFE TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at